Periostin promotes fibrosis and predicts progression in patients with idiopathic pulmonary fibrosis.
about
Recent advances in understanding idiopathic pulmonary fibrosisSearching novel diagnostic markers and targets for therapy of CKDMatrix biology of idiopathic pulmonary fibrosis: a workshop report of the national heart, lung, and blood instituteMolecular classification of idiopathic pulmonary fibrosis: personalized medicine, genetics and biomarkersThe wound healing, chronic fibrosis, and cancer progression triadPeriostin: its role in asthma and its potential as a diagnostic or therapeutic targetMolecular biomarkers in idiopathic pulmonary fibrosisLung microbiome and disease progression in idiopathic pulmonary fibrosis: an analysis of the COMET studyIdentification of key regulators for the migration and invasion of rheumatoid synoviocytes through a systems approach.Periostin and Discoidin Domain Receptor 1: New Biomarkers or Targets for Therapy of Renal Disease.Integrins as Therapeutic Targets for Respiratory DiseasesFollowing the path of CCL2 from prostaglandins to periostin in lung fibrosisThe respiratory microbiome in idiopathic pulmonary fibrosis.Fibulin-1 predicts disease progression in patients with idiopathic pulmonary fibrosisABCG2pos lung mesenchymal stem cells are a novel pericyte subpopulation that contributes to fibrotic remodeling.The role of periostin in tissue remodeling across health and disease.Periostin in intrahepatic cholangiocarcinoma: pathobiological insights and clinical implications.Inflammatory leukocyte phenotypes correlate with disease progression in idiopathic pulmonary fibrosis.Periostin responds to mechanical stress and tension by activating the MTOR signaling pathway.Extensive phenotyping of individuals at risk for familial interstitial pneumonia reveals clues to the pathogenesis of interstitial lung disease.Matrix, mesenchyme, and mechanotransductionAbsence of Vitamin K-Dependent γ-Carboxylation in Human Periostin Extracted from Fibrotic Lung or Secreted from a Cell Line Engineered to Optimize γ-Carboxylation.Models of disease behavior in idiopathic pulmonary fibrosis.Drug-induced Liver Fibrosis: Testing Nevirapine in a Viral-like Liver Setting Using Histopathology, MALDI IMS, and Gene Expression.Resveratrol ameliorates myocardial fibrosis by inhibiting ROS/ERK/TGF-β/periostin pathway in STZ-induced diabetic mice.The transcription factor scleraxis is a critical regulator of cardiac fibroblast phenotype.Six-SOMAmer Index Relating to Immune, Protease and Angiogenic Functions Predicts Progression in IPF.Endogenous Semaphorin-7A Impedes Human Lung Fibroblast DifferentiationiTRAQ-Based Proteomics Reveals Novel Biomarkers for Idiopathic Pulmonary Fibrosis.The usefulness of monomeric periostin as a biomarker for idiopathic pulmonary fibrosisNifedipine and phenytoin induce matrix synthesis, but not proliferation, in intact human gingival connective tissue ex vivo.C-type natriuretic peptide ameliorates pulmonary fibrosis by acting on lung fibroblasts in mice.Discoidin domain receptor-1 and periostin: new players in chronic kidney diseaseRoles of Periostin in Respiratory Disorders.Periostin expression induced by oxidative stress contributes to myocardial fibrosis in a rat model of high salt-induced hypertension.Fibrocytes in the Pathogenesis of Chronic Fibrotic Lung Disease.IL-25 and type 2 innate lymphoid cells induce pulmonary fibrosis.Stem cells, cell therapies, and bioengineering in lung biology and diseases. Comprehensive review of the recent literature 2010-2012.Clarithromycin attenuates IL-13-induced periostin production in human lung fibroblasts.Future directions in idiopathic pulmonary fibrosis research. An NHLBI workshop report.
P2860
Q26745905-BBFBB87C-2F98-40AE-86E0-DD8F9FD2F9E5Q26796633-B9AC02EE-2E31-4550-ADF6-27DADAEF3C98Q26852563-489F4856-2206-4652-8869-02EE25D19031Q26864836-D3156FFF-3B07-4FFF-B350-24CA49FC39E5Q27014616-03115551-0324-49AA-8CBB-9268D5B88D2DQ27021972-7E07AAD7-8662-467F-B4D1-9AFDE818E979Q27025340-54A0B196-9C8D-44C2-B62E-C398B96CDE26Q30384494-FBDF76EB-3677-4D15-911C-7CAC2B3A0321Q30564337-623474A9-9E3B-4633-B438-4179C0995DB2Q33650181-D726F6C9-1A8D-4EF2-A34A-6BDF67A0C36AQ33668635-9A5D2132-00CF-4735-9E6A-22E76A8F615AQ33799756-AD56B7C7-3B5B-449D-9EA8-859A9C24005EQ33871544-EED8C9FD-EEAB-4B41-91C7-470AC42B37D5Q34299791-336F00E7-5DFA-4F70-B7B3-B7CC4CA8B341Q34354002-2823B571-8261-4B8D-91E3-1CA0721981B2Q34379268-B7AFC9D8-1A28-4DA7-A990-976C9188C063Q34673957-EFFDDC59-B629-4986-B1D6-48C6E96C85DAQ34857355-99F51D9D-7828-4DDD-9A44-B1C02023C52EQ35071033-4912EDCB-E90E-4EA2-8308-4FA10F0BF9EEQ35153490-952A469D-7D9B-46D2-A741-C21E01E80209Q35604443-A4A90C1B-0CA3-4AF4-978D-371E231096C2Q35745864-0D810776-02AF-4D41-819E-60D9F9B7EC5BQ35786052-02DD69D2-901F-4F45-B22F-1BDFCBF731C7Q35886292-7199724F-6819-4970-9AC9-D34B0E35CB74Q35889807-3EC89E25-5D07-482F-81C6-72433206BD66Q35961854-90D1F882-0391-4DBA-985D-93C4A726A1D2Q36095068-C4F10267-F68D-4F03-8E45-4D795DA60548Q36251345-07D7878F-F879-45F3-AC66-5A8A06664ED3Q36259789-3046D2E4-4419-49BA-9C8A-A414BE4E86C7Q36326780-BD4752A0-EED4-4061-9237-F89727383BDEQ36470947-8024881D-EE21-40A0-BB7E-F4FA22F297C0Q36599813-696FC05E-5730-47F7-97BD-4E7788A19817Q36801573-43B48AE2-CE74-4B02-B964-BF73CB8794A1Q36916018-9EA53804-6D6B-4C59-B98B-1A3552335FFDQ37032185-C98A3775-3EC5-4F83-A250-B9FB924BBBA0Q37158258-685ED2D5-F505-417B-9F4E-D86334BBA5F7Q37474764-B1EB110F-8475-40A9-B6D6-B087C07D5803Q37651549-09D72A96-112E-4DF9-92C3-984661E8F670Q37655419-808057E7-376F-48E4-BA24-9A5CE1265A82Q37698325-440D084F-0915-453E-9877-5885C515DD33
P2860
Periostin promotes fibrosis and predicts progression in patients with idiopathic pulmonary fibrosis.
description
2012 nî lūn-bûn
@nan
2012 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Periostin promotes fibrosis an ...... idiopathic pulmonary fibrosis.
@ast
Periostin promotes fibrosis an ...... idiopathic pulmonary fibrosis.
@en
type
label
Periostin promotes fibrosis an ...... idiopathic pulmonary fibrosis.
@ast
Periostin promotes fibrosis an ...... idiopathic pulmonary fibrosis.
@en
prefLabel
Periostin promotes fibrosis an ...... idiopathic pulmonary fibrosis.
@ast
Periostin promotes fibrosis an ...... idiopathic pulmonary fibrosis.
@en
P2093
P2860
P50
P1476
Periostin promotes fibrosis an ...... idiopathic pulmonary fibrosis.
@en
P2093
Antonia P Popova
Barbara Carnemolla
COMET Investigators
Carol A Wilke
Carolyn M Birch
Christopher D Fry
Fernando J Martinez
J Kelley Bentley
Kevin R Flaherty
Marc B Hershenson
P2860
P304
P356
10.1152/AJPLUNG.00139.2012
P577
2012-10-05T00:00:00Z